|
Video: What is a Stock Split?
|
|
Mediwound is a biopharmaceutical company focused on developing, manufacturing and commercializing bio- therapeutic solutions for tissue repair and regeneration. Co.'s primary biopharmaceutical product, NexoBrid, is used for the removal of dead or damaged tissue, known as eschar, in adults with deep partial-thickness and full-thickness thermal burns, also referred to as severe burns. Co.'s second product candidate, EscharEx, is a topical biological drug candidate for the debridement of chronic and other hard-to-heal wounds. Co.'s third product candidate, MW005, is a topically applied biological drug candidate for the treatment of non-melanoma skin cancers. According to our Mediwound stock split history records, Mediwound has had 1 split. | |
|
Mediwound (MDWD) has 1 split in our Mediwound stock split history database. The split for MDWD took place on December 20, 2022. This was a 1 for 7 reverse split, meaning for each 7 shares of MDWD owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 142.857142857143 share position following the split.
When a company such as Mediwound conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the Mediwound stock split history from start to finish, an original position size of 1000 shares would have turned into 142.857142857143 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Mediwound shares, starting with a $10,000 purchase of MDWD, presented on a split-history-adjusted basis factoring in the complete Mediwound stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
05/06/2014 |
|
End date: |
05/03/2024 |
|
Start price/share: |
$77.63 |
|
End price/share: |
$18.65 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-75.98% |
|
Average Annual Total Return: |
-13.29% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$2,402.66 |
|
Years: |
10.00 |
|
|
|
Date |
Ratio |
12/20/2022 | 1 for 7 |
|
|